Even though costs for medications will continue to rise in 2013 by as much as four percent, the increase is projected to be less than in previous years.
"Projecting Future Drug Expenditures in U.S. Non-Federal Hospitals and Clinics" is to be published in the American Journal of Health-System Pharmacy, projects drug expenditures for this year and examines factors likely to influence drug expenditures.
St. Jude Children's Research Hospital led the analysis.
James M. Hoffman, Pharm.D., the report's principal author, said "In the aggregate, drug expenditure growth is moderating, especially in the hospital setting."
However, some specific drugs used in clincs are still increasing.
"Cancer therapies in particular stand out as costly drugs," said Hoffman.
ASHP has published this report since 1992, with Hoffman leading the team producing it since 2004.